Line 31: |
Line 31: |
| ==WHO Classification Pages (Includes Links to Content)== | | ==WHO Classification Pages (Includes Links to Content)== |
| | | |
− | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] | + | *[[HAEM4:Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] |
| | | |
− | - [[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] | + | - [[HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] |
− | - [[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] | + | - [[HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] |
− | - [[Acute Promyelocytic Leukemia (APL) with PML-RARA]] | + | - [[HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion]] |
− | - [[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] | + | - [[HAEM5:Acute myeloid leukaemia with KMT2A rearrangement|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] |
− | - [[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214|AML with t(6;9)(p23;q34.1); DEK-NUP214]] | + | - [[HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion|AML with t(6;9)(p23;q34.1); DEK-NUP214]] |
− | - [[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] | + | - [[HAEM5:Acute myeloid leukaemia with MECOM rearrangement|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] |
− | - [[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] | + | - [[HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] |
− | - [[Acute Myeloid Leukemia (AML) with BCR-ABL1|AML with BCR-ABL1]] | + | - [[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion|AML with BCR-ABL1]] |
− | - [[Acute Myeloid Leukemia (AML) with Mutated NPM1|AML with Mutated NPM1]] | + | - [[HAEM5:Acute myeloid leukaemia with NPM1 mutation|AML with Mutated NPM1]] |
− | - [[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA|AML with Biallelic Mutations of CEBPA]] | + | - [[HAEM5:Acute myeloid leukaemia with CEBPA mutation|AML with Biallelic Mutations of CEBPA]] |
− | - [[Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] | + | - [[HAEM4:Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] |
| | | |
− | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes|AML with Myelodysplasia-Related Changes]] | + | *[[HAEM5:Acute myeloid leukaemia, myelodysplasia-related|AML with Myelodysplasia-Related Changes]] |
| | | |
− | *[[Therapy-Related Myeloid Neoplasms]] | + | *[[HAEM5:Myeloid neoplasm post cytotoxic therapy]] |
| | | |
− | *[[Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]] | + | *[[HAEM4:Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]] |
| | | |
− | - [[Acute Myeloid Leukemia (AML) with Minimal Differentiation|AML with Minimal Differentiation]] | + | - [[HAEM5:Acute myeloid leukaemia with minimal differentiation|AML with Minimal Differentiation]] |
− | - [[Acute Myeloid Leukemia (AML) without Maturation|AML without Maturation]] | + | - [[HAEM5:Acute myeloid leukaemia without maturation|AML without Maturation]] |
− | - [[Acute Myeloid Leukemia (AML) with Maturation|AML with Maturation]] | + | - [[HAEM5:Acute myeloid leukaemia with maturation|AML with Maturation]] |
− | - [[Acute Myelomonocytic Leukemia]] | + | - [[HAEM5:Acute myelomonocytic leukaemia]] |
− | - [[Acute Monoblastic and Monocytic Leukemia]] | + | - [[HAEM5:Acute monocytic leukaemia]] |
− | - [[Pure Erythroid Leukemia]] | + | - [[HAEM5:Acute erythroid leukaemia]] |
− | - [[Acute Megakaryoblastic Leukemia (AMKL)]] | + | - [[HAEM5:Acute megakaryoblastic leukaemia]] |
− | - [[Acute Basophilic Leukemia]] | + | - [[HAEM5:Acute basophilic leukaemia]] |
− | - [[Acute Panmyelosis with Myelofibrosis]] | + | - [[HAEM4:Acute Panmyelosis with Myelofibrosis]] |
| | | |
− | *[[Myeloid Sarcoma]] | + | *[[HAEM5:Myeloid sarcoma]] |
| | | |
− | *[[Myeloid Proliferations Associated with Down Syndrome]] | + | *[[HAEM4:Myeloid Proliferations Associated with Down Syndrome]] |
| | | |
− | - [[Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome]] | + | - [[HAEM5:Myeloid proliferations associated with Down syndrome]] |
− | - [[Myeloid Leukemia Associated with Down Syndrome]] | + | - [[HAEM5:Myeloid proliferations associated with Down syndrome]] |
| | | |
− | *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] | + | *[[HAEM5:Blastic plasmacytoid dendritic cell neoplasm]] |
| | | |
− | *[[Acute Leukemias of Ambiguous Lineage]] | + | *[[HAEM4:Acute Leukemias of Ambiguous Lineage]] |
| | | |
− | - [[Acute Undifferentiated Leukemia]] | + | - [[HAEM5:Acute undifferentiated leukaemia]] |
− | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] |
− | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia with KMT2A rearrangement]] |
− | - [[Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid]] |
− | - [[Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia, T/myeloid]] |
− | - [[Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia, rare types]] |
− | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | + | - [[HAEM4:Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] |
| | | |
| *[[Myeloid Neoplasms with Germline Predisposition]] | | *[[Myeloid Neoplasms with Germline Predisposition]] |
| | | |
− | - [[Acute Myeloid Leukaemia with Germline CEBPA Mutation]] | + | - [[HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation]] |
− | - [[Myeloid Neoplasms with Germline DDX41 Mutation]] | + | - [[HAEM4:Myeloid Neoplasms with Germline DDX41 Mutation]] |
− | - [[Myeloid Neoplasms with Germline RUNX1 Mutation]] | + | - [[HAEM4:Myeloid Neoplasms with Germline RUNX1 Mutation]] |
− | - [[Myeloid Neoplasms with Germline ANKRD26 Mutation]] | + | - [[HAEM4:Myeloid Neoplasms with Germline ANKRD26 Mutation]] |
− | - [[Myeloid Neoplasms with Germline ETV6 Mutation]] | + | - [[HAEM4:Myeloid Neoplasms with Germline ETV6 Mutation]] |
− | - [[Myeloid Neoplasms with Germline GATA2 Mutation]] | + | - [[HAEM4:Myeloid Neoplasms with Germline GATA2 Mutation]] |
| | | |
| ==Other Related Pages (Includes Links to Content)== | | ==Other Related Pages (Includes Links to Content)== |
| | | |
− | *[[Acute Myeloid Leukemia (AML) with Mutated FLT3|AML with Mutated FLT3]] | + | *[[HAEM5:Myeloid/lymphoid neoplasm with FLT3 rearrangement|AML with Mutated FLT3]] |
− | *[[Acute Myeloid Leukemia (AML) with NUP214-ABL1|AML with NUP214-ABL1]] | + | *[[HAEM4:Acute Myeloid Leukemia (AML) with NUP214-ABL1|AML with NUP214-ABL1]] |
− | *[[Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6|AML with t(4;12)(q12;p13); CHIC2-ETV6]] | + | *[[HAEM4:Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6|AML with t(4;12)(q12;p13); CHIC2-ETV6]] |
| | | |
| ==Additional Information== | | ==Additional Information== |